Lakewood-Amedex Biotherapeutics Inc (LABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | 12-2024 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -923 | -3,848 | -540 | -4,855 | 3,650 |
| Depreciation Amortization | 31 | 120 | 30 | 52 | 2,420 |
| Accounts payable and accrued liabilities | 167 | N/A | 44 | N/A | N/A |
| Other Working Capital | 526 | 542 | 79 | -1,084 | -6,980 |
| Other Operating Activity | -150 | 1,241 | -18 | 164 | 20 |
| Operating Cash Flow | $-350 | $-1,945 | $-404 | $-5,723 | $-890 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 0 | N/A | -2 | -1,340 |
| Other Investing Activity | 0 | 0 | 0 | 3,927 | -70 |
| Investing Cash Flow | $0 | $0 | $0 | $3,925 | $-1,410 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 125 | N/A | 200 | N/A | N/A |
| Other Financing Activity | 0 | 1,500 | 0 | -50 | 2,380 |
| Financing Cash Flow | $125 | $1,500 | $200 | $-50 | $2,380 |
| Exchange Rate Effect | N/A | 0 | N/A | 0 | 8 |
| Beginning Cash Position | 236 | 681 | 681 | 2,530 | 1,370 |
| End Cash Position | 12 | 236 | 477 | 681 | 1,450 |
| Net Cash Flow | $-225 | $-445 | $-204 | $-1,849 | $80 |
| Free Cash Flow | |||||
| Operating Cash Flow | -350 | -1,945 | -404 | -5,723 | -890 |
| Free Cash Flow | -350 | -1,945 | -404 | -5,723 | -890 |